Laura de Arroyo Garcia Ph.D.

Laura de Arroyo Garcia advises clients in the health care and life sciences industry on a broad range of technology, compliance, intellectual property, and data-intensive transactions and strategic advisory matters. She has particular experience across the pharmaceutical, biotechnology, medical devices, technology, and commodities sectors, helping clients navigate new product and service launches, the deployment of emerging technologies (including artificial intelligence [AI], digital platforms, and Internet of Things [IoT]), regulatory change, and data- and IP-heavy transactions.

She has a strong technical background in bioinformatics, computational biology, and synthetic biology, as well as entrepreneurial experience gained as part of an Imperial College agritech spinout. She combines leading sector experience with rigorous academic training in the life sciences, enabling her to provide commercially informed guidance across a wide range of legal issues.

She serves as a committee member of the Imperial College London Research Ethics Committee, which reviews medium and high-risk research involving human participants undertaken at the college.

Laura's experience also encompasses patent litigation and digital regulation spanning adtech, online safety, and cyber regulatory matters. Prior to joining Jones Day in 2026, she spent significant time on a secondment to a global technology company and a global automotive company.